当前位置:首页 - 行情中心 - 新华制药(000756) - 财务分析

新华制药

(000756)

  

流通市值:69.65亿  总市值:105.47亿
流通股本:4.56亿   总股本:6.90亿

新华制药(000756)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润4.87亿元,每股收益0.69元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益521750.04万元,未分配利润255043.44万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产901960.16万元,负债380210.12万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入8,466,309,803.086,734,166,240.754,732,481,467.242,474,697,457.66
营业总成本7,940,307,572.726,337,089,365.674,414,193,942.132,328,929,009.3
营业利润534,370,670.27398,270,352.14307,569,985.06170,556,984.74
利润总额533,653,423.32392,917,627.43303,363,837.69168,771,522.02
净利润486,714,573.88355,449,271.22272,766,347.86145,264,098.4
其他综合收益56,232,510.2374,961,072.6627,326,906.39815,327.77
综合收益总额542,947,084.11430,410,343.88300,093,254.25146,079,426.17
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计3,726,840,162.913,629,565,392.313,638,665,068.83,478,605,861.68
非流动资产合计5,292,761,404.625,194,807,527.995,095,194,055.764,989,371,524.5
资产总计9,019,601,567.538,824,372,920.38,733,859,124.568,467,977,386.18
流动负债合计2,795,614,112.392,703,569,750.622,613,718,361.42,441,072,309.1
非流动负债合计1,006,487,037.81,024,795,647.631,145,493,190.421,035,944,459.8
负债合计3,802,101,150.193,728,365,398.253,759,211,551.823,477,016,768.9
归属于母公司股东权益合计4,991,588,524.784,871,406,971.824,754,065,944.574,764,918,585.13
股东权益合计5,217,500,417.345,096,007,522.054,974,647,572.744,990,960,617.28
负债和股东权益合计9,019,601,567.538,824,372,920.38,733,859,124.568,467,977,386.18
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计8,190,329,183.856,005,619,921.414,129,814,761.082,038,794,587.41
经营活动现金流出小计7,822,718,734.95,751,379,262.014,052,413,706.212,000,731,222.98
经营活动产生的现金流量净额367,610,448.95254,240,659.477,401,054.8738,063,364.43
投资活动现金流入小计8,836,9058,911,728518,48846,100
投资活动现金流出小计221,047,627.59149,687,297.5197,146,577.2452,521,398.16
投资活动产生的现金流量净额-212,210,722.59-140,775,569.51-96,628,089.24-52,475,298.16
筹资活动现金流入小计979,178,520.78959,093,430.93659,543,580.93163,552,691.73
筹资活动现金流出小计794,399,946.6823,941,865.91582,886,564.83146,763,895.9
筹资活动产生的现金流量净额184,778,574.18135,151,565.0276,657,016.116,788,795.83
汇率变动对现金及现金等价物的影响15,012,454.6512,684,524.2111,807,462.754,185,815.71
现金及现金等价物净增加额355,190,755.19261,301,179.1269,237,444.486,562,677.81
期末现金及现金等价物余额1,136,875,010.061,042,985,433.99850,921,699.35788,246,932.68
TOP↑